Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07787767 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CMV Refractory and Resistant Infection in Solid Organ Transplant Recipients in Argentina

StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study will describe the frequency and characteristics of refractory and resistant cytomegalovirus (CMV) infection in adults who received a solid organ transplant in Argentina between 2017 and 2024. Researchers will review medical records from transplant centers across the country to identify episodes of CMV infection that did not respond adequately to standard antiviral treatment (refractory) or that showed genetic mutations associated with drug resistance. The study will describe the clinical features, treatments used, and outcomes (including graft function and survival) of patients with these episodes, in order to better understand how common this problem is and what factors are associated with it in the local population.
Trial Details
NCT Number NCT07787767
Lead Sponsor Hospital Italiano de Buenos Aires
Collaborators: Takeda Pharmaceuticals North America, Inc.
Conditions
(from sponsor)		 Cytomegalovirus Infections, Solid Organ Transplantation Recipient, Solid Organ Transplantation
Related terms Cytomegalovirus Infections, Infections
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov